Health Care & Life Sciences » Medical Equipment & Supplies | Fisher & Paykel Healthcare Corp. Ltd.

Fisher & Paykel Healthcare Corp. Ltd. | Income Statement

Fiscal year is April-March. All values NZD Thousands.
2014
2015
2016
2017
2018
2019
Sales/Revenue
568,602.00
644,013.00
818,492.00
869,506.00
964,500.00
1,072
Cost of Goods Sold (COGS) incl. D&A
258,049.00
261,369.00
293,840.00
303,980.00
330,400.00
355
Gross Income
310,553.00
382,644.00
524,652.00
565,526.00
634,100.00
718
SG&A Expense
225,599.00
245,896.00
315,567.00
355,312.00
365,000.00
405
EBIT
84,954.00
136,748.00
209,085.00
210,214.00
269,100.00
313
Unusual Expense
-
3,500.00
1,300.00
300.00
700.00
25
Non Operating Income/Expense
59,433.00
31,203.00
1,996.00
31,336.00
100.00
2
Interest Expense
7,780.00
5,829.00
9,053.00
3,821.00
3,700.00
3
Pretax Income
136,664.00
158,766.00
200,830.00
238,444.00
267,800.00
286
Income Tax
39,611.00
45,593.00
57,405.00
69,292.00
77,600.00
77
Consolidated Net Income
97,053.00
113,173.00
143,425.00
169,152.00
190,200.00
209
Net Income
97,053.00
113,173.00
143,425.00
169,152.00
190,200.00
209
Net Income After Extraordinaries
97,053.00
113,173.00
143,425.00
169,152.00
190,200.00
209
Net Income Available to Common
97,053.00
113,173.00
143,425.00
169,152.00
190,200.00
209
EPS (Basic)
0.18
0.20
0.26
0.30
0.33
0.37
Basic Shares Outstanding
547,094.50
555,542.70
561,036.00
566,124.70
570,023.40
573
EPS (Diluted)
0.17
0.20
0.25
0.29
0.33
0.36
Diluted Shares Outstanding
557,553.10
569,549.00
572,037.80
574,339.20
576,449.60
578
EBITDA
114,847.00
168,396.00
244,288.00
249,276.00
313,700.00
354
Non-Operating Interest Income
57.00
144.00
102.00
415.00
1,600.00
3

About Fisher & Paykel Healthcare Corp.

View Profile
Address
15 Maurice Paykel Place
Auckland AU 2013
New Zealand
Employees -
Website http://www.fphcare.com
Updated 07/08/2019
Fisher & Paykel Healthcare Corp. Ltd. engages in the designing, manufacturing and marketing of medical device products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. It operates through the following segments: New Zealand, North America, Europe, and Asia-Pacific. New Zealand segment includes all activities controlled by entities or employees based in New Zealand, principally research and development, manufacturing, marketing, sales and distribution and administration.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.